Edit

EMBL News

beta

Lab Matters

Where do you start when developing a new medicine?

A pioneering public-private research initiative between GSK, the European Bioinformatics Institute (EMBL-EBI) and the Wellcome Trust Sanger Institute is to harness the power of ‘big data’ and genome sequencing to improve the success rate for discovering new medicines. The new Centre for Therapeutic Target Validation (CTTV) will aim to address a wide range of human […]

By Guest author(s)

Lab Matters

Pan-European imaging infrastructure gains momentum

Europe is uniting to make state-of-the-art imaging technologies accessible to biomedical researchers throughout the continent in a concerted manner. The European Molecular Biology Laboratory (EMBL) and seven countries (Belgium, Finland, Italy, Poland, Slovakia, the Netherlands, the United Kingdom) have signed the Euro- BioImaging Memorandum of Understanding. In the coming months, the signatories will work together […]

By Guest author(s)

Lab Matters

Become a member of Euro-BioImaging

Euro-BioImaging, the pan-European open access research infrastructure for biological and medical imaging technologies, invites leading European imaging facilities to submit proposals to participate. Applications to become a Euro-BioImaging node will be reviewed by a board of independent international experts. Successful facilities will be able to upgrade their capacity in order to attract and serve transnational […]

By Guest author(s)

Lab Matters

Denmark joins the Nordic EMBL Partnership for Molecular Medicine

Today, the Nordic EMBL Partnership for Molecular Medicine celebrates two important milestones: the renewal of the partnership agreement for an extended period of 10 years, and the expansion of the Nordic EMBL network with the official opening of the Danish Research Institute of Translational Neuroscience (DANDRITE) at Aarhus University, which will become its Danish node. The Nordic […]

By Guest author(s)

Lab Matters

UK invests £75 million in European research infrastructure to support knowledge-based economy

The European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today’s announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills’ Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.  ELIXIR is a pan-European effort to […]

By Guest author(s)

Lab Matters

Five countries and EMBL sign Memorandum of Understanding to make ELIXIR a reality

Today marks an important step for ELIXIR, Europe’s emerging research infrastructure for life-science information, as five countries plus the European Molecular Biology Laboratory (EMBL) have signed a Memorandum of Understanding to catalyse the implementation and construction of ELIXIR. The memorandum has been signed by Denmark, Finland, the Netherlands, Sweden and the United Kingdom, and more […]

By Guest author(s)

Lab Matters

Lennart Philipson, 1929-2011.

Obituary – Lennart Philipson

Lennart Philipson, who served as EMBL’s second Director General, has passed away. Lennart headed EMBL for over a decade between 1982-93, a crucial time for molecular biology when different scientific disciplines in the life sciences were becoming increasingly interlinked. He reorganised the laboratory into new scientific and instrumentation units, with a profound impact on both […]

By Guest author(s)

Lab Matters

Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science, and Iain Mattaj, Director-General of EMBL, signing the Memorandum of Understanding.

European Commission and EMBL renew cooperation

In a Memorandum of Understanding signed today, the European Commission (EC) and the European Molecular Biology Laboratory (EMBL) formalise their desire to maintain and further develop their cooperation. “I am delighted to sign the renewed and strengthened Memorandum of Understanding between the European Commission and the European Molecular Biology Laboratory. I am confident that it […]

By Guest author(s)

Lab Matters

BBSRC and EMBL-EBI welcome UK funds earmarked for major bioscience data infrastructure project

The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK’s Large Facilities Capital Fund for ELIXIR – the European Life-science Infrastructure for Biological Information – as announced today. ELIXIR is a pan-European initiative that aims to operate […]

By Guest author(s)

Lab Matters

Signing the declaration of accession to the EIROforum: Massimo Altarelli, Chairman of the XFEL Management Board (left) and Francesco Romanelli, Chairman of the EIROforum (right). In the back (left to right): Francesco Sette (ESRF), Felicitas Pauss (CERN), Iain Mattaj (EMBL), Richard Wagner (ILL), Rowena Sirey (ESO) and David Southwood (ESA)

European XFEL joins EIROforum

At the Autumn 2010Council meeting of the EIROforum, a partnership of seven European intergovernmental research organisations with large research infrastructures, the Directors General unanimously accepted the European X-Ray Free-Electron Laser Facility (European XFEL), based in Hamburg, Germany, to become its eighth member. The European XFEL is an international research facility supported by Denmark, France, Germany, […]

By Guest author(s)

Lab Matters

Popular in this category

EMBLetc.

Read the latest Issues of our magazine - EMBLetc.

Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.

EMBLetc. archive
Edit